April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Development of Biomarker Equations based on Multi-Dimensional Modeling of Cytokine Shifts in Retinal Diseases
Author Affiliations & Notes
  • Gianna C Teague
    Schepens Eye Research Institute, Massachusetts Eye & Ear Infirmary, Boston, MA
  • Namrata Nandakumar
    Schepens Eye Research Institute, Massachusetts Eye & Ear Infirmary, Boston, MA
  • Jie Ma
    Schepens Eye Research Institute, Massachusetts Eye & Ear Infirmary, Boston, MA
  • Kyle V Marra
    Ophthalmology, Beth Israel Deaconess Medical Center, Boston, MA
  • Jorge G Arroyo
    Ophthalmology, Beth Israel Deaconess Medical Center, Boston, MA
  • Megan E Baldwin
    Opthea Pty Ltd, Circadian Technologies Ltd, South Yarra, VIC, Australia
  • Walter Johnson
    Physics, Suffolk University, Boston, MA
  • Kameran Lashkari
    Schepens Eye Research Institute, Massachusetts Eye & Ear Infirmary, Boston, MA
  • Footnotes
    Commercial Relationships Gianna Teague, None; Namrata Nandakumar, None; Jie Ma, None; Kyle Marra, None; Jorge Arroyo, None; Megan Baldwin, Circadian Technologies Ltd (E); Walter Johnson, None; Kameran Lashkari, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1919. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gianna C Teague, Namrata Nandakumar, Jie Ma, Kyle V Marra, Jorge G Arroyo, Megan E Baldwin, Walter Johnson, Kameran Lashkari; Development of Biomarker Equations based on Multi-Dimensional Modeling of Cytokine Shifts in Retinal Diseases. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1919.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: We have hypothesized that levels of individual cytokines reflect underlying disease processes. Cumulative (multi-dimensional) shifts among cytokine families may be used to define specific disease processes and lead to novel disease-specific biomarkers.

Methods: Human vitreous samples collected from a variety of retinal diseases were subjected to multiplex analysis of cytokine markers. The five disease groups examined were proliferative diabetic retinopathy (PDR), proliferative vitreoretinopathy (PVR), retinal vascular occlusions (RVO) and neovascular glaucoma (NVG). The control samples included epiretinal membranes, floaters and macular holes. Mean, chi-squares and t-scores of log-transformed data were calculated and used to model multi-dimensional equations.

Results: From the 35 cytokines examined, 29 were selected for which a Gaussian distribution of log-transformed data was observed in the control group. Single cytokine analysis for individuals in particular disease groups showed that certain diseases were associated with large t-score shifts from the controls for specific cytokines. The three cytokines showing the greatest shifts for the diseases studied are as follows: For PDR, PLGF, VEGF-A, and TNF-α; for PVR, TIE-2, Prolactin, and FGF-basic; for RVO: PLGF, VEGF-A, and EGF; for NVG: PLGF, VEGF-A, and EGF.

Conclusions: Elevated t-scores correlate with the impact of a particular cytokine on a specific disease process. Biomarker equations could be derived from multi-dimensional t-scores to adequately predict ocular disease processes and distinguish one disease from another.

Keywords: 490 cytokines/chemokines • 763 vitreous • 468 clinical research methodology  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×